Granados-Ponce JA, Peralta-Pedrero ML, Munguía-Miranda C, López-Carmona JM, Ávila-Leyva A, Rodríguez-Moctezuma R

Language: Spanish
References: 19
Page: 285-289
PDF size: 53.86 Kb.

ABSTRACT

Objective: To determine the association between depressive symptoms not identified by the family physician and polypharmacy in patients over 60 years old.
Methods: A case-control design with non-probabilistic sampling. Inclusion criteria: ≥ 60 years old both sexes, without disease or with one disease-balanced illness, and with reliable recording in chart by the last 12 month. Exclusion criteria: cognitive deterioration, obstructive chronic lung disease, cardiopathy, infarct record, alcoholism, smoking addiction and functional dependence’s. Elimination criteria: depression’s previous diagnoses and hospitalization during a year before the study. The cases were patients who have simultaneously received 4 o more pharmacologic prescriptions in 5 of 6 last medical visits. The controls were patients who have simultaneously received 3 o less pharmacologic prescriptions in 5 of 6 last medical visits. Depressive symptoms: grading ≥ 6 (Yesavage and Brink scale).
Results: 200 patients per group, aged 69 ± 6 years agreed to participate. Logistics regression (OR;CI_95%): hypertension (6.0;3.6- 10.3), diabetes mellitus type 2 (3.7;2.3-5.9), depression (2.1;1.2- 3.4), and female sex (1.7;1.1-2.7).
Conclusions: Hypertension, diabetes mellitus type 2, depressive symptoms not identified by the family physician, and female sex are risk factors for polypharmacy in the elderly.

REFERENCES

1. Alexopoulos GS, Borson S, Cuthbert NB, Benoit D, Mulsant H, Olin J, Oslin W. Assessment of late life depression. Biol Psychiatry 2002;52:164-174.

2. Hays R, Wells KB, Sherbourne C, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gral Psychiatry 1995;52:11-19.

3. Simon G, Ormel J, Vonkorff, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:352-357.

4. Simon GE, Goldberg S, Tiemens M, Bedirhan U. Outcomes of recognized and unrecognized depression in an international primary care study. General Hospital Psychiatry 1999;21:97-105.

5. Greenberg P, Stiglin L, Finkelstein SN, Berndt E. Depression: a neglected major illness. J Clin Psychiatry 1993;54:419-424.

6. Unützer J. Diagnosis and treatment of older adults with depression in primary care. Biol Psychiatry 2002;52:285-292.

7. Volkers A, Nuyen J, Verhaak P, Shchekkevus F. The problem of diagnosing major depression in elderly primary care patients. J Affect Disord 2004;82:259-263.

8. Stek M, Gussekloo J, Beekman T, Tilburg W, Westendrop J. Prevalence, correlates and recognition of depression in the oldest old: The leiden 85-plus study. J Affect Disord 2004;78:193-200.

9. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;809-817.

10. Pirmohamed M, James S, Meakin S, Green Ch, Scott AJ, Walley Tj, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.

11. Arbas E, Garzon R, Suárez A. Consumo de medicamentos en mayores de 65 años: problemas potenciales y factores asociados. Aten Primaria 1998;22:165-70.

12. Martínez de la Iglesia J, Vilches O, Herrero D, Colomer A, Taberna A, Luque L. Versión española del cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. Medifam 2002;12:620-630.

13. Schnittker J. Chronic illness and depressive symptoms in late life. Soc Sci Med 2005;60:13-23.

14. Wolf M, Bukowski Z, Conran J, Sirotovskaya K, Kagan V, Mosnaim A. An analysis of factors contributing to polypharmacy. Biol Psychiatry 1995;37:649.

15. Pedrera Z, Canal M, Lavado G. Study on the health of the elderly in Extremadura: medication and most frequent chronic diseases. Rev Esp Salud Pública. 1999;73:10-15.

16. Veehof LJ, Steward R, Haaijer R, Ruskamp F, Meyboom B. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261-267.

17. Steward R, Moore M, May F, Marks RG, Hale WE. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991;44:1353-1359.

18. López-Torres L, Cerda R, Fernández C, Requena M. Factores asociados al consumo de medicamentos en personas ancianas. Med Clin 1997;108:56-60.

19. Lustman P, Anderson RJ, Freedland K, Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-942.